Moreover, in lung adenocarcinoma, IL-34 protein levels increased upon treatment with doxorubicin and cisplatin, suggesting a possible regulation of IL-34 in response to therapy [47]. This evidence concerns the gene IL34 and lung adenocarcinoma.